首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

1735661

全球智慧藥丸市場規模（按目標區域、應用、最終用戶、區域範圍）預測至 2025 年

Global Smart Pills Market Size By Target Area (Targeted Drug Delivery, Vital Sign Monitoring), By Application (Large Intestine, Stomach), By End-User (Hospitals, Diagnostic Centers), By Geographic Scope And Forecast

出版日期: 2025年05月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

智慧藥丸市場規模及預測

2024 年智慧藥丸市場規模價值 59.5 億美元，預計到 2032 年將達到 143.2 億美元，2026 年至 2032 年的複合年成長率為 12.8%。

智慧藥丸是一種可吞服的電子設備，內建感測器、攝影機和藥物傳輸系統，用於監測身體機能並收集即時健康資訊。這些錠劑可用於診斷、監測和定製藥物分配，從而改善患者護理。
智慧藥丸通常用於診斷胃腸道疾病、追蹤服藥依從性以及收集患者資料。它們提供了一種非侵入式的替代方案，減少了對標準醫療程序的需求。該技術提高了治療的精準度，使臨床醫生能夠更好地制定患者護理方案。
未來，智慧醫療可能會利用人工智慧來改善預測性診斷和個人化治療，其應用有望擴展到包括慢性病管理在內的各個醫學學科，從而帶來更好的醫療結果和患者滿意度。

全球智慧藥物市場動態

影響全球智慧藥丸市場的關鍵市場動態是：

關鍵市場促進因素

慢性病盛行率不斷上升：糖尿病和心血管疾病等慢性病盛行率的上升凸顯了對新型健康解決方案的需求。預計到2030年，慢性病將佔全球死亡人數的73%，促使醫療保健從業者採用智慧平板電腦來更好地管理疾病並遠端患者監護。
感測器技術的進步：微型感測器和連接模組的發展，推動了能夠監測各種生理數據的先進智慧錠劑的研發。預計2021-2026年，全球智慧藥丸市場的複合年成長率將達到8.3%，主要得益於感測器技術的進步。

主要挑戰

資料隱私問題：使用智慧藥丸追蹤健康數據引發隱私擔憂。患者的敏感資訊可能被洩漏、被駭客入侵或被濫用。確保強力的資料安全措施並遵守 HIPAA 等標準，對於維護患者信任並確保這項技術的廣泛應用至關重要。
高成本：智慧平板電腦及相關技術的設計和製造成本高昂，可能會限制其普及。高成本也給醫療保健系統和個人（尤其是在低收入地區）帶來了負擔，這嚴重阻礙了該技術的普及和公平使用。
監管障礙：智慧平板電腦的核准流程複雜，需要FDA等監管機構進行全面的安全性和有效性評估。遵循這些法律規範可能既耗時又昂貴。

主要趨勢：

人工智慧和機器學習的融合：智慧藥丸中人工智慧和機器學習的使用將提高數據處理能力，實現個人化治療和預測分析，從而獲得更好的健康結果。
重視預防性醫療保健：預防性醫療保健變得越來越重要，智慧平板電腦將在監測健康參數和促進主動疾病管理以降低醫療成本方面發揮關鍵作用。
遠端醫療的採用：遠端醫療的使用推動了對智慧藥丸的需求，透過實現遠端監控和患者與醫療保健機構的聯繫，增加了醫療保健的可及性和患者參與度。

Smart pills are ingestible electronic devices that include sensors, cameras, and medicine delivery systems. They monitor internal bodily functions and collect real-time health information. These pills are used for diagnostics, monitoring, and tailored drug distribution, which improves patient care.
Smart pills are generally used to diagnose gastrointestinal issues, track drug adherence, and collect patient data. They offer non-invasive alternatives, which reduce the need for standard medical procedures. This technology enhances treatment accuracy and enables clinicians to make better judgments about patient care.
In the future, smart medicines will use AI to improve predictive diagnosis and individualized therapy. Their use is predicted to grow in a variety of medical sectors, including chronic disease management, resulting in better healthcare results and patient satisfaction.

Global Smart Pills Market Dynamics

The key market dynamics that are shaping the global smart pills market include:

Key Market Drivers:

Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, highlights the need for novel health solutions. Chronic diseases are expected to account for 73% of global fatalities by 2030, prompting healthcare practitioners to implement smart tablets for better disease management and remote patient monitoring.
Advancements In Sensor Technology: Advancements in miniaturized sensors and connectivity modules have resulted in the development of advanced smart pills capable of monitoring a variety of physiological data. The global smart pill market is expected to develop at an 8.3% CAGR between 2021 and 2026, owing mostly to advancements in sensor technology.

Key Challenges:

Data Privacy Concerns: The usage of smart pills to track health data poses privacy issues. Sensitive patient information may be compromised, hacked, or misused. Ensuring strong data security measures and obeying to standards such as HIPAA are critical to sustaining patient trust and widespread use of this technology.
High Costs: Smart tablets and their accompanying technologies can be costly to design and manufacture, restricting availability. This high cost can also burden healthcare systems and individuals, especially in low-income areas, creating a significant barrier to universal adoption and fair access to technology.
Regulatory Hurdles: The clearance procedure for smart tablets is complex, requiring thorough safety and efficacy assessments by regulatory agencies such as the FDA. Navigating these regulatory frameworks can be time-consuming and potentially costly.

Key Trends:

Integration Of AI And Machine Learning: The use of AI and machine learning in smart pills improves data processing capabilities, allowing for tailored treatment and predictive analytics for better health results.
Focus On Preventive Healthcare: Preventive healthcare is becoming increasingly important, with smart tablets playing a critical role in monitoring health parameters and promoting proactive illness management to decrease healthcare expenditures.
Telemedicine Adoption: Telemedicine usage is boosting demand for smart pills, which allow for remote monitoring and patient-provider contact, thereby enhancing access to care and patient participation.

Global Smart Pills Market Regional Analysis

Here is a more detailed regional analysis of the global smart pills market:

North America:

According to Verified Market Research, North America is expected to dominate the global smart pills market.
The high frequency of gastrointestinal illnesses in North America promotes the use of smart tablets for diagnosis and therapy. The National Institute of Diabetes and Digestive and Kidney illnesses (NIDDK) estimates that 60 to 70 million Americans suffer from digestive illnesses. This prevalent incidence drives up the need for smart pills as a diagnostic tool.
North America's advanced healthcare infrastructure and large healthcare expenditures all contribute to the adoption of smart pills. With U.S. healthcare spending expected to exceed USD 4.1 Trillion by 2020, the region's developed healthcare system promotes the integration of cutting-edge medical technology such as smart pills, hence improving patient care.

Asia Pacific:

According to Verified Market Research, Asia Pacific is fastest growing region in global smart pills market.
The increasing prevalence of gastrointestinal illnesses in Asia Pacific is pushing the demand for smart pills. Research published in the Journal of Gastroenterology and Hepatology suggests that the prevalence of gastrointestinal problems in the region ranges from 5.5% to 34.2%.
In China, approximately 5-6% of the population suffers with irritable bowel syndrome, affecting 70-80 million people. These numbers indicate the increased healthcare needs for digestive health. As traditional techniques of diagnosis and management have limits, smart tablets provide a more advanced, non-invasive approach, making them an appealing choice for improving patient outcomes in gastrointestinal healthcare.

Global Smart Pills Market: Segmentation Analysis

The Global Smart Pills Market is segmented based Target Area, Application, End-User, and Geography.

Smart Pills Market, By Target Area

Esophagus
Small Intestine
Large Intestine
Stomach

Based on Target Area, the Global Smart Pills Market is separated into Esophagus, Small Intestine, Large Intestine, and Stomach. In the global smart pill market, the small intestine segment dominates. This is primarily due to its vital function in nutrient absorption and the growing necessity to monitor gastrointestinal illnesses. Smart tablets created for the small intestine allow for accurate detection and treatment of illnesses such as Crohn's disease and celiac disease.

Smart Pills Market, By Application

Capsule Endoscopy
Targeted Drug Delivery
Vital Sign Monitoring

Based on Application, Global Smart Pills Market is divided into Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring. Capsule endoscopy is now the most popular use for smart pills worldwide. This approach allows for non-invasive imaging of the gastrointestinal tract, which provides important diagnostic information. The rising prevalence of gastrointestinal illnesses, as well as the demand for effective diagnostic tools, propel it to market leadership, improving patient comfort and procedural efficiency.

Smart Pills Market, By End-User

Hospitals
Diagnostic Centers

Based on End-User, Global Smart Pills Market is divided into Hospitals and Diagnostic Centers. Hospitals dominate the global smart pill market because of their complete healthcare services, improved technological integration and greater use of remote monitoring systems, which improve patient care and treatment outcomes.

Key Players

The Global Smart Pills Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are GE Healthcare, Boston Scientific Corporation, Given Imaging, Inc., Olympus Corporation, BioImages Research Ltd., Medimetrics S.A. DE C.V, Karl Storz Gmbh & Co. KG, Fujifilm Holdings Corporation, Cerner Corporation, Proteus Digital Health, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Global Smart Pills Market Recent Developments
In January 2019, Proteus Digital Health delivered its first digital cancer chemotherapy tablet to aid clinicians in tracking treatment success and adherence among cancer patients.
In August 2020, Otsuka paid USD 15 million for Proteus Digital Health, a manufacturer of smart pills.

1 INTRODUCTION OF GLOBAL SMART PILLS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
3.5 Market attractiveness

4 GLOBAL SMART PILLS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL SMART PILLS MARKET, BY APPLICATION

5.1 Overview
5.2 Capsule Endoscopy
5.3 Targeted Drug Delivery
5.4 Vital Sign Monitoring

6 GLOBAL SMART PILLS MARKET, BY TARGET AREA

6.1 Overview
6.2 Esophagus
6.3 Small Intestine
6.4 Large Intestine
6.5 Stomach

7 GLOBAL SMART PILLS MARKET, BY END USER

7.1 Overview
7.2 Hospitals
7.3 Diagnostic Centers

8 GLOBAL SMART PILLS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL SMART PILLS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
9.4 ACE Matrix

10 COMPANY PROFILES

10.1 GE Healthcare
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Boston Scientific Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Given Imaging, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Olympus Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 BioImages Research Ltd.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Medimetrics S.A. DE C.V
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Karl Storz Gmbh & Co. KG
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Fujifilm Holdings Corporation
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Cerner Corporation
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Proteus Digital Health, Inc.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments